SCHEMBL31432074

SCHEMBL31432074

Cc1c(N)ccc(CN)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
TSHR P16473 1/20 0.42
PIK3CA P42336 1/20 0.42
ALDH1A1 P00352 1/20 0.35
LOXL2 Q9Y4K0 3/20 0.34
AOC1 P19801 2/20 0.33
AOC3 Q16853 2/20 0.33
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
RPS6KA1 Q15418 1/20 0.31
PNMT P11086 1/20 0.31
S100B P04271 1/20 0.31
ESR1 P03372 1/20 0.30
KCNH2 Q12809 1/20 0.30
TP53 P04637 1/20 0.30
THRB P10828 1/20 0.30
ALOX15 P16050 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31431058 0.98 CYP3A4 (0.41) CYP3A4TSHRPIK3CAALDH1A1LOXL2
SCHEMBL13743153 0.83 AOC1 (0.33) CYP3A4TSHRPIK3CAALDH1A1LOXL2
SCHEMBL6400991 0.80 LOXL2 (0.36) LOXL2RPS6KA1PNMT
SCHEMBL4621279 0.80 LOXL2 (0.38) LOXL2RPS6KA1PNMT
SCHEMBL3572188 0.79 CYP3A4 (0.42) CYP3A4TSHRPIK3CAALDH1A1AOC1
SCHEMBL29467968 0.79 LOXL2 (0.39) ALDH1A1LOXL2AOC1AOC3PNMT
SCHEMBL13527773 0.75 LOXL2 (0.48) LOXL2AOC1AOC3PNMT
SCHEMBL27674631 0.74 LOXL2 (0.34) LOXL2AOC1AOC3PNMT
SCHEMBL671337 0.73 LOXL2 (0.39) LOXL2AOC1AOC3PNMT
SCHEMBL5929976 0.73 CYP3A4 (0.59) CYP3A4TSHRPIK3CAALDH1A1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049326-A1 TRICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 BIOCRYST PHARMACEUTICALS, INC. (US) 2025-03-06 WO disclosed